Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
User 22 in our observational data highlighted this uncertainty when questioning if he really wanted to continue dosing twice daily in light of the 30-minute half-life
Research Summary BPC-157 and TB-500 blend research provides valuable insights into complementary receptor pharmacology mechanisms operating within cellular microenvironments
Stack protocol: BPC-157: 250 to 500 mcg subcutaneous, once or twice a day Inject near the injury when you can reach it TB-500: 2 to 2.5 mg subcutaneous, twice a week (loading phase) Inject away from the injury, lower abdomen or outer thigh works fine 2 mg once a week (maintenance phase) Both run at the same time through the loading phase
AOD9604 is a fragment that solely isolates effects related to fat metabolism
NAD Anti-Aging IV Therapy - $250 High dose NAD
US$ 21.45
US$ 24.87
US$ 24.88
